Search Results - "OFIARA, Linda"

Impact of rapid investigation clinic on timeliness of lung cancer diagnosis and treatment by Ezer, Nicole, Navasakulpong, Asma, Schwartzman, Kevin, Ofiara, Linda, Gonzalez, Anne V

“…Guidelines recommend timely evaluation of patients with suspected lung cancer. We evaluated the impact of a Rapid Investigation Clinic (RIC) on timeliness of…”
Get full text

Long-term outcomes of induction carboplatin and gemcitabine followed by concurrent radiotherapy with low-dose paclitaxel and gemcitabine for stage III non-small cell lung cancer by Guilbault, Catherine, MD, Garant, Aurelie, MD, Faria, Sergio, MD, Owen, Scott, MD, Ofiara, Linda, MD, Duclos, Marie, MD, Hirsh, Vera, MD, Kopek, Neil, MD

“…Abstract Background Standard treatment for unresectable stage III non-small cell lung cancer (NSCLC) is concurrent chemo-radiation (CRT). A regimen of…”
Get full text

Upper airway sensation in snoring and obstructive sleep apnea by KIMOFF, R. John, SFORZA, Emilia, CHAMPAGNE, Victoria, OFIARA, Linda, GENDRON, Daniel

“…Previous studies indicate that upper airway (UA) sensory receptors play a role in the maintenance of UA patency and contribute to arousal in response to airway…”
Get full text

Dislodgement of Radial EBUS-Guide Sheath Radiopaque Cuff: A Rare Complication by Beaudoin, Stéphane, Ofiara, Linda M, Bellerose, Marc, Gonzalez, Anne V

Get full text

Optimizing tissue sampling for the diagnosis, subtyping, and molecular analysis of lung cancer by Ofiara, Linda Marie, Navasakulpong, Asma, Beaudoin, Stephane, Gonzalez, Anne Valerie

“…Lung cancer has entered the era of personalized therapy with histologic subclassification and the presence of molecular biomarkers becoming increasingly…”
Get full text

Real-World Outcomes of Patients With Advanced Non-small Cell Lung Cancer Treated With Anti-PD1 Therapy on the Basis of PD-L1 Results in EBUS-TBNA vs Histological Specimens by Tajarernmuang, Pattraporn, Ofiara, Linda, Beaudoin, Stéphane, Wang, Hangjun, Benedetti, Andrea, Gonzalez, Anne V.

“…Programmed death-ligand 1 (PD-L1) testing is feasible in most specimens acquired using endobronchial ultrasound-guided needle aspiration (EBUS-TBNA). Are the…”
Get full text

Accuracy of Cytologic vs Histologic Specimens for Assessment of Programmed Cell Death Ligand-1 Expression in Non-Small Cell Lung Cancer by Tajarernmuang, Pattraporn, Aliaga, Felipe, Alwakeel, Amr J., Tavaziva, Gamuchirai, Turner, Kimberly, Menzies, Dick, Wang, Hangjun, Ofiara, Linda, Benedetti, Andrea, Gonzalez, Anne V.

“…Programmed cell death ligand-1 (PD-L1) expression on tumor cells, evaluated by immunohistochemistry, guides the use of immunotherapy in advanced non-small cell…”
Get full text

Off the beaten path: A case of mediastinal ectopic thyroid tissue by Robitaille, Catherine, Ofiara, Linda, Auger, Manon

Get full text

Accuracy of Cytologic vs Histologic Specimens for Assessment of Programmed Cell Death Ligand-1 Expression in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis by Tajarernmuang, Pattraporn, Aliaga, Felipe, Alwakeel, Amr J, Tavaziva, Gamuchirai, Turner, Kimberly, Menzies, Dick, Wang, Hangjun, Ofiara, Linda, Benedetti, Andrea, Gonzalez, Anne V

“…Programmed cell death ligand-1 (PD-L1) expression on tumor cells, evaluated by immunohistochemistry, guides the use of immunotherapy in advanced non-small cell…”
Get full text

Local determinants of response to endobronchial high-dose rate brachytherapy in bronchogenic carcinoma by Ofiara, L, Roman, T, Schwartzman, K, Levy, R D

“…We evaluated bronchoscopic tumor appearance and tumor location as determinants of response to high-dose rate brachytherapy (HDR-BT) in patients with…”
Get more information

Bronchoscopic tissue yield for advanced molecular testing: are we getting enough? by Tajarernmuang, Pattraporn, Ofiara, Linda, Beaudoin, Stéphane, Gonzalez, Anne V

“…The treatment of advanced lung cancer has become increasingly personalized over the past decade as a result of the improved understanding of tumor molecular…”
Get full text

Programmed Death Ligand 1 Testing of Endobronchial Ultrasound–guided Transbronchial Needle Aspiration Samples Acquired For the Diagnosis and Staging of Non–Small Cell Lung Cancer by Smith, Allister, Wang, Hangjun, Zerbo, Alix, Beaudoin, Stéphane, Ofiara, Linda, Fiset, Pierre-Olivier, Benedetti, Andrea, Gonzalez, Anne V.

“…Immunotherapy has become an integral part of management in patients with advanced non-small cell lung cancer (NSCLC). Programmed death ligand 1 (PD-L1)…”
Get full text

Transitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: Trends and Surgical Outcomes in a Regionalized Pulmonary Oncology Network by Pilon, Yohann, Rokah, Merav, Seitlinger, Joseph, Sepesi, Boris, Rayes, Roni F, Cools-Lartigue, Jonathan, Najmeh, Sara, Sirois, Christian, Mulder, David, Ferri, Lorenzo, Abdulkarim, Bassam, Ezer, Nicole, Fraser, Richard, Camilleri-Broët, Sophie, Fiset, Pierre-Olivier, Wong, Annick, Sud, Shelly, Langleben, Adrian, Agulnik, Jason, Pepe, Carmela, Shieh, Benjamin, Hirsh, Vera, Ofiara, Linda, Owen, Scott, Spicer, Jonathan D

“…Several regulatory agencies have approved the use of the neoadjuvant chemo-immunotherapy for resectable stage II and III of non-small cell lung cancer (NSCLC)…”
Get full text

Neoadjuvant Prehabilitation Therapy for Locally Advanced Non–Small-Cell Lung Cancer: Optimizing Outcomes Throughout the Trajectory of Care by Schmid, Severin, Minnella, Enrico Maria, Pilon, Yohann, Rokah, Merav, Rayes, Roni, Najmeh, Sara, Cools-Lartigue, Jonathan, Ferri, Lorenzo, Mulder, David, Sirois, Christian, Owen, Scott, Shieh, Benjamin, Ofiara, Linda, Wong, Annick, Sud, Shelly, Baldini, Gabriele, Carli, Francesco, Spicer, Jonathan

“…Prehabilitation is well established for improving outcomes in cancer surgery. Combining prehabilitation with neoadjuvant treatments may provide an opportunity…”
Get full text

Neoadjuvant Targeted Therapy in Non–Small Cell Lung Cancer and Its Impact on Surgical Outcomes by Sorin, Mark, Huynh, Caroline, Rokah, Merav, Dubé, Laurie-Rose, Rayes, Roni, Ofiara, Linda, Shieh, Benjamin, Owen, Scott, Fiset, Pierre Olivier, Cammilleri-Broët, Sophie, Najmeh, Sara, Cools-Lartigue, Jonathan, Ferri, Lorenzo, Spicer, Jonathan D.

“…The evidence for neoadjuvant targeted therapy in non–small cell lung cancer is limited, with 2 phase 3 trials currently recruiting and no approved indications…”
Get full text

Phase II multicenter trial with carboplatin and gemcitabine induction chemotherapy followed by radiotherapy concomitantly with low-dose paclitaxel and gemcitabine for stage IIIA and IIIB non-small cell lung cancer by Hirsh, Vera, Soulieres, Denis, Duclos, Marie, Faria, Sergio, Del Vecchio, Pierre, Ofiara, Linda, Ayoub, Jean-Pierre, Charpentier, Danielle, Gruber, James, Portelance, Lorraine, Souhami, Luis

“…The optimal combination of concomitant radiotherapy (RT) and chemotherapy in stage III unresectable non-small cell lung cancer (NSCLC) remains unclear. The…”
Get more information

Sequential therapy with Vinorelbine followed by Gemcitabine in patients with metastatic non small cell lung cancer (NSCLC), performance status (PS) 2, or elderly with comorbidities—a multicenter phase II trial by Hirsh, Vera, Latreille, Jean, Kreisman, Harvey, Desjardins, Pierre, Ofiara, Linda, Whittom, Renaud, Fox, Susan, Palayew, Mark David, Pintos, Javier

“…High risk patients with metastatic non small cell lung cancer (NSCLC) including patients with performance status (PS) 2 or elderly with comorbidities do poorly…”
Get full text

Weekly paclitaxel and gemcitabine chemotherapy for metastatic non-small cell lung carcinoma (NSCLC): A dose-optimizing Phase II trial by HIRSH, Vera, WHITTOM, Renaud, OFIARA, Linda, DESJARDINS, Pierre, AYOUB, Joseph, CHARPENTIER, Danielle, SMALL, David, PINTOS, Javier, LANGLEBEN, Adrian

“…The current dose-optimizing Phase II study evaluated the effect of weekly paclitaxel and gemcitabine on the response rate and survival of patients with…”
Get full text

Weekly paclitaxel and gemcitabine chemotherapy for metastatic non‐small cell lung carcinoma (NSCLC) by Hirsh, Vera, Whittom, Renaud, Ofiara, Linda, Desjardins, Pierre, Ayoub, Joseph, Charpentier, Danielle, Small, David, Pintos, Javier, Langleben, Adrian

“…BACKGROUND The current dose‐optimizing Phase II study evaluated the effect of weekly paclitaxel and gemcitabine on the response rate and survival of patients…”
Get full text